ERBB2 and breast cancer: To investigate the link between CD73 expression and T lymphocyte infiltration in BC, we first characterized CD73 protein levels in a retrospective cohort of 215 BC patients, including the three molecular subtypes, i.e., Luminal (LumA), HER2 and triple-negative (TN) BC (Table 1 for detailed description of the retrospective cohort studied).